What breathing-related risk is highlighted with Verorab rabies vaccine in infants born at 28 weeks’ gestation or earlier?

Primary doses of Verorab rabies vaccine carry a potential risk of apnoea in infants born at 28 weeks’ gestation or earlier, requiring consideration of respiratory monitoring for 48–72 hours, particularly with a history of respiratory immaturity.